Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883032 · ClinicalTrials.gov registry record · NA
Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions
A NA study of Refractive Errors, sponsored by PlenOptika.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT06883032 is a NA study of Refractive Errors that has completed, run by PlenOptika. The registered enrollment target is 92 participants, roughly in line with the 100-participant average among 14 other Refractive Errors trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06883032, a NA study of Refractive Errors, has completed, sponsored by PlenOptika.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
At the New England College of Optometry in Boston, MA, subjects ages 18-65 who have received or are receiving treatment for refractive error who choose to enroll in the study will be evaluated using subjective refraction and automated refraction, by way of the QuickSee Plus refractor. Subjects will then be randomized into one of two treatment plans: receive glasses from automated refraction first then subjective refraction second, and vice versa. After one week of wearing the first pair of glasses, patient preferences are assessed, and glasses are switched. After a week of wearing the second pair of glasses from the alternate measurement method, patient preferences are again assessed. Patients may then decide which pair patient like best. This is a triple blind, case-crossover clinical trial.
Conditions Studied
Interventions
- OTHER AR Eyeglasses first, SR Eyeglasses second
- OTHER SR Eyeglasses first, AR Eyeglasses second
Study Locations (1)
Massachusetts
- New England College of Optometry (NECO) Center for Eye Care of Commonwealth - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2025-02-16 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06883032
The ClinicalTrials.gov registry entry for NCT06883032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 100-participant average among 14 other Refractive Errors trials with a reported enrollment target. The listed sponsor is PlenOptika, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 2 interventions - of which AR Eyeglasses first, SR Eyeglasses second is the first listed.
NCT06883032 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06883032 about?
NCT06883032 is a clinical study titled "Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions". At the New England College of Optometry in Boston, MA, subjects ages 18-65 who have received or are receiving treatment for refractive error who choose to enroll in the study will be evaluated using subjective refraction and automated refraction, by way of the QuickSee Plus refractor. Subjects will ...
What is the current status of trial NCT06883032?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2025-02-16. Estimated completion is 2025-02-28.
What conditions does trial NCT06883032 study?
This clinical trial studies the following conditions: Refractive Errors.
What interventions are being tested in trial NCT06883032?
The interventions under investigation include: AR Eyeglasses first, SR Eyeglasses second (OTHER), SR Eyeglasses first, AR Eyeglasses second (OTHER).
Who is sponsoring clinical trial NCT06883032?
This trial is sponsored by PlenOptika, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06883032 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Errors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
COMPLETED · NA
-
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
COMPLETED · NA
-
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
COMPLETED · NA
-
DD T2 Daily Disposable Registration Trial
COMPLETED · NA
-
Clinical Assessment of a HYDRAGLYDE® Regimen
COMPLETED · NA
-
Assessing Fitting Guides in Alcon Multifocal Contact Lenses
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.